Joonghun Pharmaceutical Lorient Cross-linked Hyaluronic Acid with Lidocaine - HSA Registration DE0510188
Access comprehensive regulatory information for Joonghun Pharmaceutical Lorient Cross-linked Hyaluronic Acid with Lidocaine in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0510188 and owned by Joonghun Pharmaceutical Co., Ltd.. The device was registered on December 30, 2024.
This page provides complete registration details including product owner information, registrant details, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Lorient is an injectable gel for the treatment of facial defects such as lipoatrophy by restoring volume to the desired correction of facial contours, wrinkles, and folds. 路 Lorient No. 2 is indicated to be used for superficial dermis injection for fine facial wrinkles and folds or for facial defects. 路 Lorient No. 4 is indicated to be used for mid to deep dermis injection for moderate to severe facial wrinkles and nasolabial folds. 路 Lorient No. 6 is indicated to be used for subcutaneous to supraperiosteal injection for cheek augmentation to correct age-related volume defects in mid facial area.